Advertisement
Canada Markets open in 8 hrs 41 mins
  • S&P/TSX

    21,740.20
    -159.79 (-0.73%)
     
  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     
  • DOW

    37,735.11
    -248.13 (-0.65%)
     
  • CAD/USD

    0.7246
    -0.0008 (-0.1036%)
     
  • CRUDE OIL

    85.90
    +0.49 (+0.57%)
     
  • BTC-CAD

    85,532.66
    -4,043.14 (-4.51%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,401.90
    +18.90 (+0.79%)
     
  • RUSSELL 2000

    1,975.71
    -27.47 (-1.37%)
     
  • 10-Yr Bond

    4.6280
    +0.1290 (+2.87%)
     
  • NASDAQ futures

    17,844.50
    -31.75 (-0.18%)
     
  • VOLATILITY

    19.23
    +1.92 (+11.09%)
     
  • FTSE

    7,965.53
    -30.05 (-0.38%)
     
  • NIKKEI 225

    38,358.79
    -874.01 (-2.23%)
     
  • CAD/EUR

    0.6825
    +0.0001 (+0.01%)
     

At US$75.86, Is It Time To Put Albemarle Corporation (NYSE:ALB) On Your Watch List?

Albemarle Corporation (NYSE:ALB), which is in the chemicals business, and is based in United States, received a lot of attention from a substantial price increase on the NYSE over the last few months. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. But what if there is still an opportunity to buy? Let’s examine Albemarle’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

See our latest analysis for Albemarle

What's the opportunity in Albemarle?

Good news, investors! Albemarle is still a bargain right now. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that Albemarle’s ratio of 14.04x is below its peer average of 20.73x, which suggests the stock is undervalued compared to the Chemicals industry. What’s more interesting is that, Albemarle’s share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

What kind of growth will Albemarle generate?

NYSE:ALB Past and Future Earnings, January 14th 2020
NYSE:ALB Past and Future Earnings, January 14th 2020

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by a double-digit 11% over the next couple of years, the outlook is positive for Albemarle. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? Since ALB is currently undervalued, it may be a great time to increase your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on ALB for a while, now might be the time to enter the stock. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy ALB. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed buy.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Albemarle. You can find everything you need to know about Albemarle in the latest infographic research report. If you are no longer interested in Albemarle, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.